Literature DB >> 33926029

Comparison of Pregnancy Outcomes Using Different Gestational Diabetes Diagnostic Criteria and Treatment Thresholds in Multiethnic Communities between Two Tertiary Centres in Australian and New Zealand: Do They Make a Difference?

Lili Yuen1, Vincent W Wong2,3, Louise Wolmarans4, David Simmons1.   

Abstract

INTRODUCTION: Australia, but not New Zealand (NZ), has adopted the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria to diagnose gestational diabetes (GDM). We compared pregnancy outcomes using these different diagnostic approaches.
METHOD: Prospective data of women with GDM were collected from one NZ (NZ) and one Australian (Aus) hospital between 2007-2018. Aus screening criteria with 2-step risk-based 50 g Glucose Challenge Testing (GCT) followed by 75 g-oral glucose tolerance testing (OGTT): fasting ≥ 5.5, 2-h ≥ 8.0 mmol/L (ADIPS98) changed to a universal OGTT and fasting ≥5.1, 1-h ≥ 10, 2-h ≥ 8.5 mmol/L (IADPSG). NZ used GCT followed by OGTT with fasting ≥ 5.5, 2-h ≥ 9.0 mmol/L (NZSSD); in 2015 adopted a booking HbA1c (NZMOH). Primary outcome was a composite of macrosomia, perinatal death, preterm delivery, neonatal hypoglycaemia, and phototherapy. An Aus subset positive using NZSSD was also defined.
RESULTS: The composite outcome odds ratio compared to IADPSG (1788 pregnancies) was higher for NZMOH (934 pregnancies) 2.227 (95%CI: 1.84-2.68), NZSSD (1344 pregnancies) 2.19 (1.83-2.61), and ADIPS98 (3452 pregnancies) 1.91 (1.66-2.20). Composite outcomes were similar between the Aus subset and NZ.
CONCLUSIONS: The IADPSG diagnostic criteria were associated with the lowest rate of composite outcomes. Earlier NZ screening with HbA1c was not associated with a change in adverse pregnancy outcomes.

Entities:  

Keywords:  Australia; IADPSG; New Zealand; diagnostic criteria; gestational diabetes; high BMI; multiethnic; perinatal outcomes; treatment threshold

Year:  2021        PMID: 33926029     DOI: 10.3390/ijerph18094588

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  43 in total

1.  The interrelationship between ethnicity and obesity on obstetric outcomes.

Authors:  Gladys A Ramos; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 2.  International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.

Authors:  Boyd E Metzger; Steven G Gabbe; Bengt Persson; Thomas A Buchanan; Patrick A Catalano; Peter Damm; Alan R Dyer; Alberto de Leiva; Moshe Hod; John L Kitzmiler; Lynn P Lowe; H David McIntyre; Jeremy J N Oats; Yasue Omori; Maria Ines Schmidt
Journal:  Diabetes Care       Date:  2010-03       Impact factor: 17.152

3.  Gestational diabetes mellitus in five ethnic groups: a comparison of their clinical characteristics.

Authors:  V W Wong
Journal:  Diabet Med       Date:  2012-03       Impact factor: 4.359

4.  Confounding effect of ethnic diversity on booking-in body mass index and prevalence of gestational diabetes and hypertensive disorders in pregnant women in western Sydney 1997-2016.

Authors:  James Brown; Supuni Kapurubandara; Therese M McGee
Journal:  Aust N Z J Obstet Gynaecol       Date:  2019-10-07       Impact factor: 2.100

Review 5.  Ethnic Disparities in Gestational Diabetes.

Authors:  Lili Yuen; Vincent W Wong; David Simmons
Journal:  Curr Diab Rep       Date:  2018-07-23       Impact factor: 4.810

6.  Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk.

Authors:  Sheree L Boulet; Greg R Alexander; Hamisu M Salihu; MaryAnn Pass
Journal:  Am J Obstet Gynecol       Date:  2003-05       Impact factor: 8.661

7.  The ADIPS pilot National Diabetes in Pregnancy Audit Project.

Authors:  David Simmons; N Wah Cheung; H David McIntyre; Jeff R Flack; Janet Lagstrom; Dianne Bond; Elizabeth Johnson; Louise Wolmarans; Peter Wein; Ashim K Sinha
Journal:  Aust N Z J Obstet Gynaecol       Date:  2007-06       Impact factor: 2.100

8.  Metformin versus insulin for the treatment of gestational diabetes.

Authors:  Janet A Rowan; William M Hague; Wanzhen Gao; Malcolm R Battin; M Peter Moore
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

9.  In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus.

Authors:  Raimunda S S Azevedo; Jorge R de Sousa; Marialva T F Araujo; Arnaldo J Martins Filho; Bianca N de Alcantara; Fernanda M C Araujo; Maria G L Queiroz; Ana C R Cruz; Beatriz H Baldez Vasconcelos; Jannifer O Chiang; Lívia C Martins; Livia M N Casseb; Eliana V da Silva; Valéria L Carvalho; Barbara C Baldez Vasconcelos; Sueli G Rodrigues; Consuelo S Oliveira; Juarez A S Quaresma; Pedro F C Vasconcelos
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

10.  Changing diagnostic criteria for gestational diabetes in Sweden - a stepped wedge national cluster randomised controlled trial - the CDC4G study protocol.

Authors:  Helena Fadl; Maryam Saeedi; Scott Montgomery; Anders Magnuson; Erik Schwarcz; Kerstin Berntorp; Verena Sengpiel; Elisabeth Storck-Lindholm; Helena Strevens; Anna-Karin Wikström; Sophia Brismar-Wendel; Martina Persson; Stefan Jansson; Fredrik Ahlsson; Carina Ursing; Linda Ryen; Kerstin Petersson; Ulla-Britt Wennerholm; Karin Hildén; David Simmons
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-01       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.